Share Price and Basic Stock Data
Last Updated: January 8, 2026, 7:03 pm
| PEG Ratio | -0.59 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Uflex Ltd, a prominent player in the packaging and containers industry, reported a current market capitalization of ₹3,510 Cr, with its stock trading at ₹486. The company’s revenue from operations for the fiscal year ended March 2023 stood at ₹14,663 Cr, reflecting a growth trajectory from ₹13,127 Cr in the previous year. The trailing twelve months (TTM) revenue reached ₹15,282 Cr, indicating a continuous upward trend. Quarterly sales figures show fluctuations, with Sep 2023 sales at ₹3,369 Cr, slightly up from ₹3,258 Cr in Jun 2023, yet lower than the ₹3,768 Cr recorded in Sep 2022. This variability in quarterly performance suggests that while Uflex is expanding its revenue base, it faces challenges in maintaining consistent growth, influenced by market demand and operational efficiency.
Profitability and Efficiency Metrics
Uflex reported a net profit of ₹390 Cr for the fiscal year ending March 2025, down significantly from ₹1,099 Cr in March 2022, indicating a notable decline in profitability. The operating profit margin (OPM) stood at 10% for the latest fiscal year, with quarterly OPM showing slight improvements, reaching 12% in both Jun 2025 and Dec 2024. However, the return on equity (ROE) was only 3.29%, highlighting underperformance compared to industry standards. The company’s interest coverage ratio (ICR) was reported at 2.63x, suggesting that while Uflex can cover its interest obligations, the margin is thin. The cash conversion cycle (CCC) was recorded at 101 days, indicating a longer period for converting investments in inventory into cash, which can strain liquidity.
Balance Sheet Strength and Financial Ratios
Uflex’s balance sheet reflects a total debt of ₹9,326 Cr against reserves of ₹7,655 Cr, signaling a debt-to-equity ratio of 1.10x, which is on the higher side compared to industry norms. The company’s long-term debt to equity stood at 0.65x, indicating a significant reliance on borrowed funds. The current ratio was reported at 1.31x, suggesting adequate short-term liquidity, while the quick ratio was lower at 0.91x, indicating potential challenges in meeting immediate obligations without liquidating inventory. The book value per share increased to ₹1,023, reflecting a stable asset base despite the pressures on profitability. Furthermore, the price-to-book value (P/BV) ratio of 0.48x indicates that the market may undervalue Uflex compared to its net assets, presenting a potential opportunity for value investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Uflex indicates a stable promoter holding of 44.58%, which has remained consistent over recent quarters. Foreign institutional investors (FIIs) held 7.75% as of Sep 2025, showing a slight increase from previous periods, which may indicate growing confidence among foreign investors. Domestic institutional investors (DIIs) remain minimal at 0.52%, suggesting limited institutional interest in the stock. Public shareholding stood at 47.16%, which reflects a diversified ownership structure. The total number of shareholders has declined from 57,626 in Dec 2022 to 44,372 by Sep 2025, raising concerns about retail investor confidence. This decline could be attributed to the company’s recent profitability challenges, impacting investor sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Uflex faces both opportunities and challenges. The potential for growth lies in the expanding packaging market as consumer demand rises, but this is tempered by operational inefficiencies and high debt levels. The company must enhance its operational performance to improve profitability, particularly in managing its cash conversion cycle and reducing debt. Risks include fluctuations in raw material prices and economic downturns that could impact demand. Moreover, the company’s relatively low ROE compared to industry norms poses a concern for investors seeking strong returns. In navigating these challenges, Uflex could focus on strategic partnerships and operational improvements to bolster its market position and investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Tin Works Ltd | 124 Cr. | 119 | 217/107 | 11.3 | 210 | 0.67 % | 7.95 % | 5.88 % | 10.0 |
| Gujarat Containers Ltd | 94.0 Cr. | 166 | 188/154 | 13.6 | 94.4 | 0.90 % | 18.4 % | 17.4 % | 10.0 |
| Goblin India Ltd | 16.4 Cr. | 11.8 | 34.5/10.3 | 22.1 | 32.8 | 0.00 % | 7.73 % | 4.63 % | 10.0 |
| G K P Printing & Packaging Ltd | 15.2 Cr. | 6.92 | 10.4/4.85 | 18.6 | 10.4 | 0.00 % | 4.87 % | 3.87 % | 10.0 |
| Garware Hi Tech Films Ltd | 6,900 Cr. | 2,976 | 4,953/2,317 | 22.1 | 1,079 | 0.40 % | 20.6 % | 15.0 % | 10.0 |
| Industry Average | 1,902.76 Cr | 308.43 | 53.54 | 189.00 | 0.34% | 12.76% | 24.70% | 7.38 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,768 | 3,483 | 3,380 | 3,258 | 3,369 | 3,309 | 3,426 | 3,654 | 3,833 | 3,735 | 3,814 | 3,901 | 3,832 |
| Expenses | 3,356 | 3,219 | 3,011 | 2,975 | 2,984 | 2,978 | 3,060 | 3,245 | 3,441 | 3,281 | 3,404 | 3,447 | 3,446 |
| Operating Profit | 412 | 264 | 370 | 284 | 386 | 332 | 366 | 408 | 392 | 454 | 410 | 454 | 386 |
| OPM % | 11% | 8% | 11% | 9% | 11% | 10% | 11% | 11% | 10% | 12% | 11% | 12% | 10% |
| Other Income | 81 | -70 | -52 | -362 | 20 | -64 | -319 | -149 | -73 | 65 | 132 | 21 | 29 |
| Interest | 105 | 133 | 130 | 135 | 132 | 140 | 128 | 162 | 178 | 174 | 184 | 199 | 188 |
| Depreciation | 146 | 144 | 166 | 160 | 164 | 166 | 165 | 173 | 173 | 172 | 176 | 187 | 189 |
| Profit before tax | 242 | -83 | 22 | -373 | 110 | -39 | -247 | -76 | -31 | 173 | 182 | 89 | 38 |
| Tax % | 21% | 3% | 96% | 12% | 42% | 72% | 10% | 30% | 108% | 21% | 7% | 35% | 29% |
| Net Profit | 191 | -85 | 1 | -416 | 63 | -67 | -271 | -98 | -65 | 137 | 169 | 58 | 27 |
| EPS in Rs | 26.41 | -11.83 | 0.12 | -57.63 | 8.77 | -9.31 | -37.51 | -13.63 | -8.95 | 18.95 | 23.34 | 8.03 | 3.73 |
Last Updated: December 28, 2025, 5:36 pm
Below is a detailed analysis of the quarterly data for Uflex Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 3,832.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,901.00 Cr. (Jun 2025) to 3,832.00 Cr., marking a decrease of 69.00 Cr..
- For Expenses, as of Sep 2025, the value is 3,446.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3,447.00 Cr. (Jun 2025) to 3,446.00 Cr., marking a decrease of 1.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 386.00 Cr.. The value appears to be declining and may need further review. It has decreased from 454.00 Cr. (Jun 2025) to 386.00 Cr., marking a decrease of 68.00 Cr..
- For OPM %, as of Sep 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 12.00% (Jun 2025) to 10.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Jun 2025) to 29.00 Cr., marking an increase of 8.00 Cr..
- For Interest, as of Sep 2025, the value is 188.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 199.00 Cr. (Jun 2025) to 188.00 Cr., marking a decrease of 11.00 Cr..
- For Depreciation, as of Sep 2025, the value is 189.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 187.00 Cr. (Jun 2025) to 189.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 89.00 Cr. (Jun 2025) to 38.00 Cr., marking a decrease of 51.00 Cr..
- For Tax %, as of Sep 2025, the value is 29.00%. The value appears to be improving (decreasing) as expected. It has decreased from 35.00% (Jun 2025) to 29.00%, marking a decrease of 6.00%.
- For Net Profit, as of Sep 2025, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 58.00 Cr. (Jun 2025) to 27.00 Cr., marking a decrease of 31.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 3.73. The value appears to be declining and may need further review. It has decreased from 8.03 (Jun 2025) to 3.73, marking a decrease of 4.30.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:28 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,826 | 6,130 | 6,366 | 6,505 | 6,802 | 7,957 | 7,405 | 8,889 | 13,127 | 14,663 | 13,364 | 15,036 | 15,282 |
| Expenses | 5,137 | 5,395 | 5,561 | 5,630 | 5,921 | 6,969 | 6,324 | 7,085 | 10,956 | 12,913 | 11,976 | 13,344 | 13,577 |
| Operating Profit | 688 | 735 | 805 | 874 | 881 | 988 | 1,081 | 1,804 | 2,171 | 1,749 | 1,387 | 1,692 | 1,704 |
| OPM % | 12% | 12% | 13% | 13% | 13% | 12% | 15% | 20% | 17% | 12% | 10% | 11% | 11% |
| Other Income | 29 | 18 | 38 | 25 | 22 | 19 | 28 | 23 | 71 | -21 | -745 | -51 | 248 |
| Interest | 233 | 187 | 176 | 187 | 197 | 218 | 225 | 229 | 322 | 473 | 536 | 698 | 746 |
| Depreciation | 267 | 279 | 286 | 318 | 352 | 381 | 403 | 456 | 537 | 599 | 655 | 695 | 724 |
| Profit before tax | 217 | 286 | 382 | 395 | 354 | 409 | 481 | 1,142 | 1,382 | 656 | -549 | 248 | 482 |
| Tax % | 7% | 11% | 17% | 11% | 12% | 23% | 23% | 26% | 20% | 27% | 26% | 43% | |
| Net Profit | 202 | 256 | 317 | 351 | 312 | 315 | 371 | 844 | 1,099 | 481 | -691 | 142 | 390 |
| EPS in Rs | 27.92 | 35.28 | 43.46 | 48.26 | 43.00 | 43.46 | 51.21 | 116.73 | 152.09 | 66.57 | -95.69 | 19.71 | 54.05 |
| Dividend Payout % | 9% | 8% | 7% | 7% | 5% | 5% | 4% | 2% | 2% | 5% | -1% | 15% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 26.73% | 23.83% | 10.73% | -11.11% | 0.96% | 17.78% | 127.49% | 30.21% | -56.23% | -243.66% | 120.55% |
| Change in YoY Net Profit Growth (%) | 0.00% | -2.90% | -13.10% | -21.84% | 12.07% | 16.82% | 109.72% | -97.28% | -86.45% | -187.43% | 364.21% |
Uflex Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 15% |
| 3 Years: | 5% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -8% |
| 3 Years: | -40% |
| TTM: | 28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 11% |
| 3 Years: | -11% |
| 1 Year: | -31% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 4, 2025, 2:09 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 |
| Reserves | 2,751 | 2,935 | 3,376 | 3,572 | 3,907 | 4,232 | 4,625 | 5,484 | 6,624 | 7,433 | 7,153 | 7,324 | 7,655 |
| Borrowings | 2,416 | 2,210 | 2,139 | 2,102 | 2,079 | 2,105 | 3,626 | 4,041 | 4,787 | 5,704 | 6,947 | 8,353 | 9,326 |
| Other Liabilities | 1,356 | 1,250 | 1,217 | 1,402 | 1,629 | 1,550 | 1,693 | 2,222 | 2,959 | 3,229 | 3,176 | 3,687 | 3,725 |
| Total Liabilities | 6,595 | 6,468 | 6,804 | 7,148 | 7,688 | 7,960 | 10,016 | 11,820 | 14,441 | 16,438 | 17,348 | 19,437 | 20,779 |
| Fixed Assets | 3,378 | 3,240 | 3,255 | 3,394 | 3,766 | 3,759 | 3,808 | 5,032 | 6,417 | 7,786 | 8,223 | 8,739 | 9,009 |
| CWIP | 74 | 32 | 229 | 498 | 196 | 261 | 2,007 | 1,518 | 671 | 466 | 538 | 725 | 1,320 |
| Investments | 126 | 138 | 111 | 76 | 85 | 42 | 199 | 205 | 212 | 191 | 170 | 145 | 131 |
| Other Assets | 3,017 | 3,058 | 3,210 | 3,180 | 3,641 | 3,898 | 4,003 | 5,065 | 7,141 | 7,994 | 8,416 | 9,828 | 10,319 |
| Total Assets | 6,595 | 6,468 | 6,804 | 7,148 | 7,688 | 7,960 | 10,016 | 11,820 | 14,441 | 16,438 | 17,348 | 19,437 | 20,779 |
Below is a detailed analysis of the balance sheet data for Uflex Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 72.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 72.00 Cr..
- For Reserves, as of Sep 2025, the value is 7,655.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,324.00 Cr. (Mar 2025) to 7,655.00 Cr., marking an increase of 331.00 Cr..
- For Borrowings, as of Sep 2025, the value is 9,326.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 8,353.00 Cr. (Mar 2025) to 9,326.00 Cr., marking an increase of 973.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 3,725.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,687.00 Cr. (Mar 2025) to 3,725.00 Cr., marking an increase of 38.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 20,779.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 19,437.00 Cr. (Mar 2025) to 20,779.00 Cr., marking an increase of 1,342.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 9,009.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,739.00 Cr. (Mar 2025) to 9,009.00 Cr., marking an increase of 270.00 Cr..
- For CWIP, as of Sep 2025, the value is 1,320.00 Cr.. The value appears strong and on an upward trend. It has increased from 725.00 Cr. (Mar 2025) to 1,320.00 Cr., marking an increase of 595.00 Cr..
- For Investments, as of Sep 2025, the value is 131.00 Cr.. The value appears to be declining and may need further review. It has decreased from 145.00 Cr. (Mar 2025) to 131.00 Cr., marking a decrease of 14.00 Cr..
- For Other Assets, as of Sep 2025, the value is 10,319.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,828.00 Cr. (Mar 2025) to 10,319.00 Cr., marking an increase of 491.00 Cr..
- For Total Assets, as of Sep 2025, the value is 20,779.00 Cr.. The value appears strong and on an upward trend. It has increased from 19,437.00 Cr. (Mar 2025) to 20,779.00 Cr., marking an increase of 1,342.00 Cr..
However, the Borrowings (9,326.00 Cr.) are higher than the Reserves (7,655.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 686.00 | 733.00 | 803.00 | 872.00 | 879.00 | 986.00 | -2.00 | -3.00 | -2.00 | -4.00 | -5.00 | -7.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 94 | 90 | 85 | 93 | 104 | 94 | 96 | 99 | 98 | 80 | 94 | 91 |
| Inventory Days | 60 | 63 | 64 | 70 | 72 | 63 | 73 | 89 | 86 | 91 | 84 | 100 |
| Days Payable | 86 | 72 | 80 | 98 | 108 | 79 | 90 | 104 | 92 | 85 | 90 | 90 |
| Cash Conversion Cycle | 69 | 80 | 68 | 64 | 68 | 78 | 79 | 83 | 92 | 87 | 88 | 101 |
| Working Capital Days | 22 | 23 | 23 | 22 | 36 | 32 | 31 | 45 | 56 | 41 | 36 | 20 |
| ROCE % | 9% | 9% | 10% | 10% | 9% | 10% | 10% | 15% | 17% | 10% | 6% | 8% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 40,093 | 0.18 | 2.4 | 40,093 | 2025-04-22 15:56:52 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 19.71 | -95.69 | 66.57 | 152.09 | 116.73 |
| Diluted EPS (Rs.) | 19.71 | -95.69 | 66.57 | 152.09 | 116.73 |
| Cash EPS (Rs.) | 118.09 | -3.17 | 150.56 | 226.63 | 179.94 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1023.00 | 1000.53 | 1039.38 | 927.25 | 769.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1023.00 | 1000.53 | 1039.38 | 927.25 | 769.49 |
| Revenue From Operations / Share (Rs.) | 2082.23 | 1850.62 | 2030.49 | 1817.87 | 1231.21 |
| PBDIT / Share (Rs.) | 254.02 | 211.36 | 261.17 | 315.74 | 253.01 |
| PBIT / Share (Rs.) | 157.79 | 120.59 | 178.22 | 241.35 | 189.90 |
| PBT / Share (Rs.) | 36.51 | -74.24 | 91.88 | 191.42 | 158.17 |
| Net Profit / Share (Rs.) | 21.86 | -93.94 | 67.61 | 152.25 | 116.83 |
| NP After MI And SOA / Share (Rs.) | 19.71 | -95.69 | 66.57 | 152.09 | 116.73 |
| PBDIT Margin (%) | 12.19 | 11.42 | 12.86 | 17.36 | 20.54 |
| PBIT Margin (%) | 7.57 | 6.51 | 8.77 | 13.27 | 15.42 |
| PBT Margin (%) | 1.75 | -4.01 | 4.52 | 10.53 | 12.84 |
| Net Profit Margin (%) | 1.04 | -5.07 | 3.32 | 8.37 | 9.48 |
| NP After MI And SOA Margin (%) | 0.94 | -5.17 | 3.27 | 8.36 | 9.48 |
| Return on Networth / Equity (%) | 1.92 | -9.57 | 6.41 | 16.42 | 15.16 |
| Return on Capital Employeed (%) | 8.78 | 7.20 | 11.10 | 16.81 | 15.67 |
| Return On Assets (%) | 0.73 | -3.98 | 2.92 | 7.60 | 7.12 |
| Long Term Debt / Equity (X) | 0.65 | 0.57 | 0.46 | 0.45 | 0.50 |
| Total Debt / Equity (X) | 1.10 | 0.93 | 0.73 | 0.68 | 0.64 |
| Asset Turnover Ratio (%) | 0.81 | 0.79 | 0.63 | 0.64 | 0.62 |
| Current Ratio (X) | 1.31 | 1.46 | 1.56 | 1.64 | 1.55 |
| Quick Ratio (X) | 0.91 | 1.09 | 1.08 | 1.19 | 1.18 |
| Inventory Turnover Ratio (X) | 6.75 | 3.88 | 3.36 | 4.03 | 3.85 |
| Dividend Payout Ratio (NP) (%) | 5.07 | -3.13 | 4.50 | 1.64 | 1.71 |
| Dividend Payout Ratio (CP) (%) | 0.86 | -60.99 | 2.00 | 1.10 | 1.11 |
| Earning Retention Ratio (%) | 94.93 | 103.13 | 95.50 | 98.36 | 98.29 |
| Cash Earning Retention Ratio (%) | 99.14 | 160.99 | 98.00 | 98.90 | 98.89 |
| Interest Coverage Ratio (X) | 2.63 | 2.85 | 3.98 | 7.07 | 7.98 |
| Interest Coverage Ratio (Post Tax) (X) | 1.48 | 1.36 | 2.35 | 4.53 | 4.68 |
| Enterprise Value (Cr.) | 10561.28 | 8579.76 | 6834.46 | 8380.47 | 5629.29 |
| EV / Net Operating Revenue (X) | 0.70 | 0.64 | 0.46 | 0.63 | 0.63 |
| EV / EBITDA (X) | 5.76 | 5.62 | 3.62 | 3.68 | 3.08 |
| MarketCap / Net Operating Revenue (X) | 0.23 | 0.21 | 0.16 | 0.33 | 0.30 |
| Retention Ratios (%) | 94.92 | 103.13 | 95.49 | 98.35 | 98.28 |
| Price / BV (X) | 0.48 | 0.40 | 0.32 | 0.65 | 0.49 |
| Price / Net Operating Revenue (X) | 0.23 | 0.21 | 0.16 | 0.33 | 0.30 |
| EarningsYield | 0.03 | -0.23 | 0.19 | 0.24 | 0.30 |
After reviewing the key financial ratios for Uflex Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -95.69 (Mar 24) to 19.71, marking an increase of 115.40.
- For Diluted EPS (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -95.69 (Mar 24) to 19.71, marking an increase of 115.40.
- For Cash EPS (Rs.), as of Mar 25, the value is 118.09. This value is within the healthy range. It has increased from -3.17 (Mar 24) to 118.09, marking an increase of 121.26.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,023.00. It has increased from 1,000.53 (Mar 24) to 1,023.00, marking an increase of 22.47.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,023.00. It has increased from 1,000.53 (Mar 24) to 1,023.00, marking an increase of 22.47.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,082.23. It has increased from 1,850.62 (Mar 24) to 2,082.23, marking an increase of 231.61.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 254.02. This value is within the healthy range. It has increased from 211.36 (Mar 24) to 254.02, marking an increase of 42.66.
- For PBIT / Share (Rs.), as of Mar 25, the value is 157.79. This value is within the healthy range. It has increased from 120.59 (Mar 24) to 157.79, marking an increase of 37.20.
- For PBT / Share (Rs.), as of Mar 25, the value is 36.51. This value is within the healthy range. It has increased from -74.24 (Mar 24) to 36.51, marking an increase of 110.75.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 21.86. This value is within the healthy range. It has increased from -93.94 (Mar 24) to 21.86, marking an increase of 115.80.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -95.69 (Mar 24) to 19.71, marking an increase of 115.40.
- For PBDIT Margin (%), as of Mar 25, the value is 12.19. This value is within the healthy range. It has increased from 11.42 (Mar 24) to 12.19, marking an increase of 0.77.
- For PBIT Margin (%), as of Mar 25, the value is 7.57. This value is below the healthy minimum of 10. It has increased from 6.51 (Mar 24) to 7.57, marking an increase of 1.06.
- For PBT Margin (%), as of Mar 25, the value is 1.75. This value is below the healthy minimum of 10. It has increased from -4.01 (Mar 24) to 1.75, marking an increase of 5.76.
- For Net Profit Margin (%), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 5. It has increased from -5.07 (Mar 24) to 1.04, marking an increase of 6.11.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 8. It has increased from -5.17 (Mar 24) to 0.94, marking an increase of 6.11.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.92. This value is below the healthy minimum of 15. It has increased from -9.57 (Mar 24) to 1.92, marking an increase of 11.49.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.78. This value is below the healthy minimum of 10. It has increased from 7.20 (Mar 24) to 8.78, marking an increase of 1.58.
- For Return On Assets (%), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 5. It has increased from -3.98 (Mar 24) to 0.73, marking an increase of 4.71.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.65. This value is within the healthy range. It has increased from 0.57 (Mar 24) to 0.65, marking an increase of 0.08.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.10. This value exceeds the healthy maximum of 1. It has increased from 0.93 (Mar 24) to 1.10, marking an increase of 0.17.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.81. It has increased from 0.79 (Mar 24) to 0.81, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 1.5. It has decreased from 1.46 (Mar 24) to 1.31, marking a decrease of 0.15.
- For Quick Ratio (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has decreased from 1.09 (Mar 24) to 0.91, marking a decrease of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.75. This value is within the healthy range. It has increased from 3.88 (Mar 24) to 6.75, marking an increase of 2.87.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 5.07. This value is below the healthy minimum of 20. It has increased from -3.13 (Mar 24) to 5.07, marking an increase of 8.20.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 20. It has increased from -60.99 (Mar 24) to 0.86, marking an increase of 61.85.
- For Earning Retention Ratio (%), as of Mar 25, the value is 94.93. This value exceeds the healthy maximum of 70. It has decreased from 103.13 (Mar 24) to 94.93, marking a decrease of 8.20.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 99.14. This value exceeds the healthy maximum of 70. It has decreased from 160.99 (Mar 24) to 99.14, marking a decrease of 61.85.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.63. This value is below the healthy minimum of 3. It has decreased from 2.85 (Mar 24) to 2.63, marking a decrease of 0.22.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 3. It has increased from 1.36 (Mar 24) to 1.48, marking an increase of 0.12.
- For Enterprise Value (Cr.), as of Mar 25, the value is 10,561.28. It has increased from 8,579.76 (Mar 24) to 10,561.28, marking an increase of 1,981.52.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 1. It has increased from 0.64 (Mar 24) to 0.70, marking an increase of 0.06.
- For EV / EBITDA (X), as of Mar 25, the value is 5.76. This value is within the healthy range. It has increased from 5.62 (Mar 24) to 5.76, marking an increase of 0.14.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 24) to 0.23, marking an increase of 0.02.
- For Retention Ratios (%), as of Mar 25, the value is 94.92. This value exceeds the healthy maximum of 70. It has decreased from 103.13 (Mar 24) to 94.92, marking a decrease of 8.21.
- For Price / BV (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has increased from 0.40 (Mar 24) to 0.48, marking an increase of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 24) to 0.23, marking an increase of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from -0.23 (Mar 24) to 0.03, marking an increase of 0.26.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Uflex Ltd:
- Net Profit Margin: 1.04%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.78% (Industry Average ROCE: 12.76%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.92% (Industry Average ROE: 24.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.48
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.91
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11 (Industry average Stock P/E: 53.54)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.1
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.04%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Packaging & Containers | 305, Third Floor, Bhanot Corner, New Delhi Delhi 110048 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashok Chaturvedi | Chairman & Managing Director |
| Mr. Jeevaraj Gopal Pillai | Whole Time Director |
| Mrs. Sujit Kumar Varma | Independent Director |
| Mr. Ghyanendra Nath Bajpai | Independent Director |
| Mrs. Rashmi Verma | Independent Director |
| Mr. Paresh Nath Sharma | Independent Director |
FAQ
What is the intrinsic value of Uflex Ltd?
Uflex Ltd's intrinsic value (as of 08 January 2026) is ₹311.71 which is 35.73% lower the current market price of ₹485.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,499 Cr. market cap, FY2025-2026 high/low of ₹686/438, reserves of ₹7,655 Cr, and liabilities of ₹20,779 Cr.
What is the Market Cap of Uflex Ltd?
The Market Cap of Uflex Ltd is 3,499 Cr..
What is the current Stock Price of Uflex Ltd as on 08 January 2026?
The current stock price of Uflex Ltd as on 08 January 2026 is ₹485.
What is the High / Low of Uflex Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Uflex Ltd stocks is ₹686/438.
What is the Stock P/E of Uflex Ltd?
The Stock P/E of Uflex Ltd is 11.0.
What is the Book Value of Uflex Ltd?
The Book Value of Uflex Ltd is 1,070.
What is the Dividend Yield of Uflex Ltd?
The Dividend Yield of Uflex Ltd is 0.62 %.
What is the ROCE of Uflex Ltd?
The ROCE of Uflex Ltd is 7.75 %.
What is the ROE of Uflex Ltd?
The ROE of Uflex Ltd is 3.29 %.
What is the Face Value of Uflex Ltd?
The Face Value of Uflex Ltd is 10.0.